GEN Exclusives

More »

GEN News Highlights

More »
Aug 23, 2013

Okapi and Novartis Focus on Felines

  • Okapi Sciences and Novartis Animal Health have entered an agreement to jointly develop and commercialize an antiviral treatment for cats. The drug could potentially be the first antiviral small molecule specifically developed for veterinary use.

    In collaboration with Novartis Animal Health, Okapi will finalize the clinical work and apply for marketing authorization at the EMA and FDA. Okapi Sciences will receive payments if milestones are achieved, as well as royalties on any eventual sales of the product.

    This agreement follows a grant Okapi was awarded in May from the Agency for Innovation by Science and Technology in Flanders for the development of antiviral drugs to treat viral infections in domestic cats.

    Okapi was cofounded by professors Johan Neyts, Stefaan Wera, Ph.D., and Erwin Blomsma, Ph.D., in 2007. They acquired IP in 2008 from three universities—Katholieke Universiteit Leuven, University of Liège, and the Prague Institute of Organic Chemistry and Biochemistry

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »